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There are many indications that the effects of endotoxin upon blood vessels 
(1), leucocytes (2, 3), and coagulation (4-5) are important in production of the 
Shwartzman reaction. The effects of endotoxin upon blood vessels and leuco- 
cytes cannot be  disputed, but  involvement of platelets in  the  intravascular 
clotting  of  the  Shwartzman  phenomenon  has  never  been  established  with 
certainty. 
Thrombin (7) and immunologic reactions (8), in addition to bacterial endo- 
toxin  (9),  can provoke the Shwartzman phenomenon and affect coagulation. 
Platelets influence the rate of coagulation (15) and must be present in in ~tro 
studies to demonstrate acceleration of coagulation by endotoxin or antigen- 
antibody reactions  (15-18).  Andcoagulation prevents  the  Shwartzman reac- 
tion, regardless of the anticoagulant used  (10-12).  Increased fibrinolysis pre- 
vents (13), and blockade of fibrinolysis enhances (14), the reaction. These facts 
suggest strongly that intravascular clotting possibly involving platelets may be 
essential in production of the Shwartzman reaction. 
It has not been possible to produce thrombocytopenia selectively except with 
specific platelet antiserum. Therefore, studies were done to evaluate the effect 
of immunologically induced thrombocytopenia upon the local and generalized 
Shwartzman phenomena. Administration of antiplatelet serum to rabbits pre- 
pared  with  thorotrast produced  renal  lesions  characteristic  of the  reaction. 
Immunologic thrombocytopenla did  not  inhibit  the  cutaneous hemorrhagic 
lesion of the local Shwartzman phenomenon produced by sequential injections 
of endotoxin intracutaneously and  intravenously. 
Materials and Methods 
Animols.--Albino New Zealand  rabbits, weighing  approximately  5 pounds, and fed stand- 
ard laboratory food  and water ad lib, were used in all of the studies. 
Thorotreat.--A sterile, stabilized,  colloidal  suspension of thorium dioxide (24 to 26 per cent 
by volume) obtained from Fellows-Testagar  Co., Inc., Detroit, was given intravenously  in a 
dose of 10 ml per animal. 
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Materials given intravenously were dissolved and diluted in sterile, pyrogen-free, 0.85 per 
cent NaC1 immediately prior to injection. 
Endotoxin.--Lyophilized  lipopolysaccharide  of Escherichia coli 026:B6 was obtained from 
Difco Laboratories, Inc., Detroit. 
Platda Antiserum.--Platelet antiserum was prepared by immunization of guinea pigs with 
thrice washed rabbit platelets prepared from platelet rich rabbit plasma. The platelets were 
injected initially into  the  foot-pad after emulsification  with complete  Freund's adjuvant 
(Difco Laboratories, Inc.), and subsequently,  subcutaneously  after emulsification  with in- 
complete  Freund's adjuvant  (Difco Laboratories, Inc.). The subcutaneous  injections were 
given at weekly intervals for 3 months. At that time, serum was obtained and adsorbed with 
washed rabbit erythrocytes. Sera were tested for agglutinins against washed rabbit platelets 
and for the ability to cause thrombocytopenia in normal rabbits. One-half ml of pooled anti- 
serum caused a reduction in the platelet count to less than  10,000 within 30 minutes after 
intravenous injection. 
Guinea Pig Anti-Rabbit  Albumin  and Antigamma  Globulin.--Rabbit  albumin (Baltimore 
Biological Laboratories, West Chester, Pennsylvania) and rabbit gamma globulin (Mann Re- 
search  Laboratories, New York)  were emulsified with incomplete  Freund's adjuvant (Difco 
Laboratories, Inc.) and injected subcutaneously  into guinea  pigs at weekly intervals for 3 
months.  Serum was obtained 2 weeks after the last injection and was tested for the presence 
of the corresponding  precipitating antibodies. 
Sheep-Anti-Rabbit  Gamma Globulin.--Obtained  from  Baltimore Biological Laboratories. 
Platdet  Counts.--Platelet  counts were determined in duplicate, using phase microscopy, 
according to the method of Brecher and Cronkite (19). 
White Blood Cell Counts.--Total white blood cell counts,  were determined in duplicate, 
using a Coulter Counter,  as described by Richar and Breakell (20). 
Pathologic Studies.--Animals were killed for pathological examination by the intravenous 
injection of lethal doses of sodium  pentobarbital. Autopsies were  performed  immediately 
following sacrifice, and the abdominal organs examined.  Tissues  were fixed in  10 per cent 
formalin, and sections were stained with hematoxylin-eosin. 
RESULTS 
The effect of thrombocytopenia has not been investigated in previous studies 
on  the  production  of  the  Shwartzman  phenomenon.  A  method  capable  of 
producing  thrombocytopenia  in  the  rabbit  without  inducing  concomitant 
leucopenia is by the employment of specific antiserum against rabbit platelets. 
Guinea pig antiserum against rabbit platelets in a  dose of 0.5 ml was injected 
intravenously into a group of rabbits. This produced marked thrombocytopenia 
within 30 minutes after injection. The platelet count fell below 10,000 per mm  3, 
remained  at  this level for  about  6  hours,  and  thereafter  gradually increased 
until at 24 hours it was approximately 30 per cent of the initial count. During 
this period, no significant leucopenia was observed (Text-fig. 1). 
The  administration  of  platelet  antiserum  did  not  result  in  renal  cortical 
necrosis or significant deposition of "fibrinoid" material in the renal glomeruli 
characteristic of the generalized Shwartzman phenomenon. Occasional scattered 
glomeruli, however, appeared to contain minimal amounts of hyaline material 
(Fig. 1 a  and 1 b). 
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ments  were  done  to assure  an  experimental  method  that  would  consistently 
produce  the generalized  Shwartzman phenomenon.  Ten ml of thorotrast  was 
administered  intravenously  to  a  group  of animals,  and  18  hours  later  each 
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T~xz-Fm. 1. Effect of 0.5 ml rabbit platelet  guinea pig antiserum  (PAS) administered 
intravenously  upon the platelet  and leucocyte count  of  normal  rabbits;  showing  prompt 
development of thrombocytopenia with no appreciable change in leucocyte count. 
TABLE I 
Production of the Generalized Shwartzman Phenomenon 
Protocol of i.v. injections  Renal lesions (No.  msitive total animals) 
Thorotrast (0 hrs.), endotoxin (18 hrs.) ........................... 
PAS alone .................................................... 
Thorotrast (0 hrs.), PAS (17 hrs.), endotoxin (18 hrs.) .............. 
Thorotrast (0 hrs.), PAS (18 hrs.) ................................ 
Thorotrast alone ............................................... 
Endotoxin alone ............................................... 








animal  received  50/zg of E.  coli  endotoxin  intravenously.  The  animals  were 
autopsied at time of death or 24 hours later, and tissues preserved for histologic 
study. 
There was renal cortical necrosis and marked deposition of fibrinoid material 
in the glomeruli in 66 per cent of the animals tested  (Table I). These changes 
were  characteristic  of  the  generalized  Shwartzman  phenomenon  (Fig.  1  c). 238  PLATELETS  AND  SHVCARTZM.AN PIIENOM~NON 
The  animals  developed  marked  leucopenia  and  thrombocytopenia  within  2 
hours after receiving the endotoxin  (Text-fig.  2).  It is noteworthy that  many 
animals  demonstrated both leucocytosis and thrombocytopenia  18 hours after 
receiving thorotrast  and prior to receiving endotoxin, although  in no instance 
was the platelet  count below 10,000 per mm  3 prior to administration  of endo- 
toxin. The level of circulating platelets prior to injection of endotoxin did not 
appear to influence the subsequent production of the renal lesions characteristic 
of the generalized  Shwartzman  phenomenon. 
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T~xT-FzG. 2.  Effect of 50 #g E. coli endoto~n intravenously upon the platelet and total 
leucocyte count of rabbits given 10 ml thorotrast intravenously 18 hours previously. Zero 
hour is 18 hours after injection of thorotrast and immediately prior to injection of endotoxin. 
The effect of Thrombocytopenia upon the Generalized Shwartzman Phenomenon. 
--To determine whether circulating platelets were required for the development 
of fibrinoid deposits in the glomeruli and renal cortical necrosis in animals pre- 
pared with thorotrast and then challenged with endotoxin, the following experi- 
ment was performed. 
A group of animals was given 10 ml of thorotrast intravenously and 17 hours 
later  each animal  received 0.5 ml of platelet  antiserum  intravenously.  These 
animals  developed severe thrombocytopenia  without  leucopenia immediately 
after the intravenous administration  of the platelet antiserum (Text-fig. 3). One 
hour following the administration  of the platelet antiserum and 18 hours after 
administration  of thorotrast  the animals  received 50/zg  of E. coli endotoxin 
intravenously.  Thrombocytopenia  persisted  and  leucopenia  developed  (Text- lACK  LEVIN  AND  LEIGHTON  E.  CLUFF  239 
fig.  3).  The  animals  were  autopsied at  time of death or 24 hours later,  and 
tissues preserved for histologic  study. 
Severe thrombocytopenia, induced by platelet antiserum prior to administra- 
tion  of a  provocative dose of endotoxin did not prevent  the appearance  of 
fibrinoid material in the glomeruli and renal cortical necrosis in thorotrast pre- 
pared animals.  Changes characteristic of the generalized  Shwartzman phenom- 
enon occurred in 6 of the 8 animals in this group (Table I). 
The Effect  of Platelet Antiserum upon  Animals Prepared with  Thorotrast.-- 
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Tv.xT-Fz~. 3.  Changes in total leucocyte count and platelet count in rabbits given 10 ml 
Thorotrast intravenously, followed  17 hours later by 0.5 ml PAS intravenously. 50/zg endo- 
toxin was given 1 hour after administration of the PAS. Zero hour is immediately prior to the 
injection of PAS. 
The  effect  of  platelet  antiserum  alone  in  thorotrast  prepared  rabbits  was 
evaluated in the following experiments. 
Ten ml of thorotrast was administered intravenously to a group of rabbits 
and  18 hours later  the animals  received 0.5  ml  of platelet antiserum  intra- 
venously. These rabbits developed severe thrombocytopenia within 1 hour after 
receiving  the platelet antiserum, but did not develop leucopenia (Text-fig.  4). 
The animals were autopsied and tissues preserved for study as before. Five of 
the  11  animals  (45  per  cent)  developed renal  lesions  characteristic  of  the 
generalized  Shwartzman phenomenon (Table I  and Fig.  1 d). 
The administration  of 50/zg of endotoxin 1 hour after the intravenous ad- 
ministration  of 0.5  ml of platelet antiserum did not result in changes  in the 240  PLATELETS  AND  SHWARTZMAN  PHENOMENON 
kidney different from those seen after platelet antisermn alone (Table I). The 
administration of either 10 ml of thorotrast alone or 50 #g of endotoxin alone 
did not result in the renal changes characteristic of the generalized Shwartzman 
phenomenon (Table I). 
Production  of the Local (Cutaneous) Shwartzman Phenomenon.--Prelin'finary 
studies  were  carried  out  to  produce  an  experimental  method  that  would 
consistently produce the local Shwartzman phenomenon. 
A group of rabbits received 50 ~g of endotoxin intracutaneously and 18 hours 
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TxxT-Fm. 4. Changes in total leucocyte count and platelet count in rabbits given 10 ml 
thorotrast intravenously, followed 18 hours later by 0.5 ml of PAS intravenously. Sho~ing 
thrombocytopenia  but no leucopenia attributable to the PAS. 
later each animal received 75 #g of endotoxin intravenously. Six hours after 
the second dose of endotoxin, the skin sites were examined. The animals were 
sacrificed as before, and the skin biopsied for histologic study" as described in 
Materials and Methods. 
Significant  leucopenia  developed  in  all  animals,  but  thrombocytopenia 
developed in only half of the animals in this group after the administration of 
endotoxin intravenously (Text-fig. 5). Three of the 4 rabbits developed intra- 
dermal  hemorrhages,  intravascular  thromboses,  and  a  marked  leucocytic 
infiltration,  characteristic  of the  local  Shwartzman  phenomenon  (Fig.  2  a). 
There appeared to be no relationship between the changes in circulating levels 
of platelets and white blood cells and the severity of the cutaneous lesions. JACK  LEVIN AND  LEIGHTON  E.  CLUFF  241 
The Effect o/Tkrombocytopenia  upon the Local'Skwartzman  Pkenomenon.--To 
evaluate  the effect of thrombocytopenia upon the development of the local 
Shwartzman phenomenon, a group of rabbits was pretreated with 4 intravenous 
injections of 0.5 ml of platelet antiserum during the 48 hour period preceding 
the first injection of endotoxin. These 4 injections of platelet antiserum were 
spaced approximately 10 hours apart and the last injection was given 4 hours 
prior  to the intracutaneous  injection  of 50 #g of endotoxin.  Eighteen  hours 
later, each animal  received 75  /zg of endotoxln intravenously. Development of 
cutaneous lesions was studied as before. 
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TExT-FIG. 5.  Changes in platelet count in normal rabbits and rabbits made thrombocyto- 
penic with PAS (2 ml), when endotoxin intracutaneously (50 #g) and intravenously (75/~g) 
was given to produce a  local Shwartzman reaction. 
Although the rabbits pretreated with platelet antiserum had platelet levels 
far  below those of the control group  (Text-fig.  5),  and  they developed less 
leucopenia, 75 per cent of the animals  (the same per cent as the control group) 
demonstrated  the  characteristic  gross  and  histologic  picture  of  the  local 
Shwartzman phenomenon (Table II and Fig. 2 b). Included among the animals 
demonstrating  these changes  was one whose platelet  count  remained  below 
10,000 per mm  8 during the entire experiment. 
The administration of 50 gg of endotoxin intracutaneously followed 18 hours 
later by 0.5 ml of platelet antiserum did not produce the local  Shwartzman 
phenomenon (Table II). 
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with Thorotrast.--Since platele[ antiserum was shown to produce lesions in the 
kidney similar to those of the generalized Shwartzman phenomenon, additional 
experiments were conducted to determine whether antibodies against rabbit 
albumin or globulin would also produce the changes characteristic of this reac- 
tion. 
Three groups of 8 rabbits received 10 ml of thorotrast intravenously, and 18 
hours later each group received either 0.5 ml of guinea pig anti-rabbit albumin, 
0.5 ml of guinea pig anti-rabbit gamma globulin, or 0.5 ml of sheep anti-rabbit 
gamma globulin. The animals were sacrificed and autopsied as before. 
In no instance did the rabbits demonstrate renal lesions after provocation by 
these various antisera. Each of the antisera were shown to possess precipitins 
for their respective antigen, and the guinea pig and sheep antigamma globulin 
TABLE II 
Production of the Local (Cutaneous) Shwartzman Phenomenon  il S loioo, No  Protocol  positive total animals) 
Endotoxin  i.c.  (0  hrs.),  endotoxin  i.v.  (18  hrs.)  .....................  3/4 
PAS*, Endotoxin  i.c.  (0  hrs.),  endotoxin  i.v.  (18  hrs.)  ...............  3/4 
Endotoxin  i.c.  (0  hrs.),  PAS i.v.  (18  hrs.)  .........................  0/4 
* 4 intravenous  injections  of 0.5 ml platelet antiserum administered  during 48 hours prior 
to endotoxin  injection. 
produced hemorrhagic cutaneous reactions when inoculated intradermally in 
normal animals. 
DISCUSSION 
Many  of the agents used to provoke the generalized Shwartzman phenom- 
enon accelerate coagulation (4-6, 18). In  in  vitro  studies (16-18), platelets 
are  required  for  the demonstration of  acceleration  of  eoagtflation.  Thrombocyto- 
penia without leucopenia has not been previously studied to evaluate the role 
of the platelet  in the Shwartzman reaction.  Much attention has been given to 
the role  of white  blood cells,  however, in  the  production of  this  complex phenom- 
enon (2,  3).  It  seems clear  that granulocytes are essential  for induction of renal 
cortical  necrosis  or local  cutaneous hemorrhage characteristic  of the local  and 
generalized Shwartzman  phenomenon  induced with endotoxin. Intravascular 
coagulation also  has been suggested to  be important in  the pathogenesis of these 
reactions (4-6,  8, 10-12, 21, 22).  In previous studies  of the role  of grantflocytes, 
the methods employed to induce grannlocytopenia  may have also interfered 
with normal platelet function. The investigations reported here show  that 
immunologic thromboeytopenia does not inhibit  the local  Shwartzman reaction. JACK  LEVIN  AND  LEIGHTON  E.  CLUFF  243 
In addition, platelet antiserum produces renal lesions similar  to that produced 
by endotoxin in thorotrast pretreated animals. 
Local  Shwartzman  Phenomenon.--Development  of  the  local  Shwartzman 
reaction in thrombocytopenic animals,  even when the platelet count was below 
10,000 per mm  3, suggests strongly that platelets may be of little importance in 
the pathogenesis of this reaction.  Furthermore,  the Shwartzman phenomenon 
can be prevented by administration of nitrogen mustard, in doses that produce 
granulocytopenia but minimal or no thrombocytopenia (2, 23). 
Intravascular  coagulation presumably is involved in the production of the 
local Shwartzman reaction, since anticoagulation will prevent the local Shwartz- 
man reaction (10, 11). The observation that thrombocytopenia does not prevent 
the reaction suggests, therefore, that the intravascular coagulation important in 
the pathogenesis of the reaction may not involve platelets. Additional studies 
are required to determine the specific clotting factors implicated in the local 
Shwartzman phenomenon. 
The intravascular thrombi in the hemorrhagic skin lesion of the local Shwartz- 
man  reaction are largely composed of packed white blood ceils and  for this 
reason are often referred to as "leucocyte thrombi"  (24, 25).  Anticoagulants 
may act only to interfere with leucocyte aggregation by an effect on clotting of 
plasma.  It seems possible that  the thrombosis in the cutaneous Shwartzman 
reaction is initiated  by procoagulant  activity derived from local cellular  or 
tissue damage  (26);  platelets may be involved secondarily. The preparative 
skin injection of endotoxin inducing local inflammation with granulocyte infil- 
tration (24) might activate or release the so-called "extrinsic" or  tissue throm- 
boplastins,  resulting  in  thrombosis  following  the  intravenous  provocative 
endotoxin injection (27). The findings indicate that  platelets are not primarily 
involved in the thrombosis characteristic of the local Shwartzman reaction. 
Generalized Shwartzman Phenomenon.--Renal  cortical necrosis  was not pre- 
vented when the platelet antiserum was administered prior to the provocative 
endotoxin injection. Indeed, the antiserum itself produced renal lesions typical 
of the generalized  Shwartzman reaction after thorotrast preparation, without a 
provocative injection of endotoxin. It was not possible, therefore, in the experi- 
mental  model  employed, to  induce  thrombocytopenia persisting  throughout 
the period of time required for the preparative and provocative injections of 
thorotrast  and  endotoxin.  Whether  or not thrombocytopenia suppresses the 
reaction is unknown, but thrombocytopenia induced with platelet antiserum a 
few hours after administration  of thorotrast  provokes renal  lesions  indistin- 
guishable from the generalized  Shwartzman phenomenon. 
It  has  been shown  that  heterologous antigen  administered  to  specifically 
immunized animals  can provoke the generalized  Shwartzman  reaction in ap- 
propriately prepared rabbits (8). It is possible that platelet antiserum provoked 
the reaction in a similar manner but the current studies employed heterologous 244  PLATELETS AND  SHWARTZMAN  PHENOMENON 
antiserum against the platelets of normal recipients,  rather than a heterologous 
antigen in immunized recipients.  It might be expected that a heterologous anti- 
body against any circulating  antigen of the recipient animal could provoke the 
generalized  Shwartzman  reaction.  However, it  was shown that  heterologous 
antibody (sheep  and  guinea pig)  against  rabbit  albumin or gamma  globulin 
did not provoke the renal reaction in animals prepared with thorotrast. 
Production of the generalized  Shwartzman phenomenon with platelet anti- 
serum suggests that  the rapid  destruction  or removal of platelets  in appro- 
priately prepared animals  is capable of producing this reaction. It is not known 
whether or not the platelets are lysed or removed from the circulation by the 
antiserum. Injected radioactive labeled platelets are predominantly sequestered 
in spleen and lung, but there is suggestive evidence that platelets may become 
attached  to  or  aggregated  along  capillary  endothelium  (28).  It  is  possible, 
therefore,  that  platelet  antiserum  may  enable  localization  of  platelets  in 
glomerular  capillaries  and, in that way, provoke the generalized  Shwartzman 
reaction. Evidence has been presented that platelets are importantly concerned 
with the initiation and/or acceleration of intravascular coagulation resulting  in 
the changes characteristic  of the generalized  Shwartzman  reaction  (4,  6,  16, 
17). Furthermore, anticoagulation inhibits the generalized Shwartzman reaction 
(11, 12). 
Granulocytic infiltration of the renal cortex and glomeruli is not a feature of 
the generalized  Shwartzman reaction, but circulating  granulocytes are involved 
as granulocytopenia unassociated with  thrombocytopenia the prevents renal 
lesion  (2,  23).  Platelet  antiserum,  however,  was  capable  of  producing  the 
generalized  Shwartzman  reaction in thorotrast prepared animals,  but did not 
cause a  marked leucopenia.  It is likely that  the effects of endotoxin both on 
circulating  leucocytes and platelets are involved in the generalized  Shwartzman 
reaction.  Some of the provocative agents used may exert their effect through 
one cell rather than another. Leucocyte injury with activation of granulocyte 
lysosomes may affect platelets and/or activate coagulation. 
SUMMARY 
Studies  are  reported  on  the  effect  of  immunologically  induced  thrombo- 
cytopenia upon the local and generalized  Shwartzman phenomena. Intravenous 
injection  of antiplatelet  serum  to  rabbits  produced profound but  transient 
thrombocytopenia unaccompanied by significant  changes  in circulating  leuco- 
cytes. Platelet antiserum alone given to rabbits prepared with thorotrast pro- 
duced renal lesions characteristic of the Shwartzman reaction.  Thrombocyto- 
penia induced by platelet antiserum did not inhibit the cutaneous hemorrhagic 
lesion of the local Shwartzman phenomenon produced by sequential injections 
of endotoxin  intracutaneously  and  intravenously.  The  implications  of these 
observations in the pathogenesis of the local cutaneous and generalized Shwartz- 
man reaction are discussed. JACK LEVIN AND LEIGHTON E.  CLUFF  245 
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EXPLANATION OF PLATES 
PLATE 17 
FIGS. 1 a to 1 d. Effect of platelet antiserum (PAS) upon the generalized Shwartz- 
man reaction. 
FIG. 1 a. Normal kidney. ×  400. 
FIG.  1 b. Minimal hyaline changes  in giomerulus  following injection of platelet 
antiserum alone. ×  400. 
FIG. 1 c. Fibrinoid glomerular change and cortical necrosis produced by preparation 
of animal with intravenous thorotrast (10 ml) and provocation of reaction by intra- 
venous endotoxin (50 ~g) 18 hours later. Animal sacrificed 24 hours after injection of 
endotoxin. × 400. 
FIG. 1 d. Fibrinoid giomerular change and some cortical necrosis produced by prepa- 
ration of animal with intravenous thorotrast (10 ml) and intravenous injection of PAS 
(0.5 ml) 18 hours later. Animal sacrificed 24 hours after administration of PAS. ×  400. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  17 
(Levin and Cluff:  Platelets and Shwartzman phenomenon) PLATE 18 
Fins. 2 a and 2 b. Local Shwartzman phenomenon. 
FIG. 2  a. Thrombosis,  leucocytic exudate,  and  hemorrhage  in  rabbit  skin  pre- 
pared by intracutaneous injection of 50 vg endotoxin followed 18 hours later by intra- 
venous  injection of  75  #g  endotoxin.  Skin  biopsied 24  hours  after  the  intravenous 
injection. ×  400. 
FIG. 2 b. Skin lesion identical with Fig. 2 a, produced with endotoxin intracutane- 
ously and intravenously as in Fig. 2 a, in rabbits made thrombocytopenic by 4 repeated 
injections of PAS over a  48 hour period prior to the intracutaneous and intravenous 
injection of endotoxin.  ×  400. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  18 
(Levin and Cluff: Platelets and Shwartzman phenomenon) 